Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanoma.

Nature communications·2026

Same author

Variations in the latitudinal diversity gradients of the ocean microbiome.

Cell host & microbe·2026

Same author

Complete genomes of <i>E. coli</i> with diverse K antigens.

Microbiology resource announcements·2026

Same author

NLRP1 inflammasome activation in skin equivalents reveals mechanistic insights into the roles of keratinocytes in psoriasis.

Cell death & disease·2026

Same author

In silico typing maps the natural diversity of Escherichia coli transporter-dependent capsules.

Nature microbiology·2026

Same author

Osmotolerance is a driver of microbial carbon processes in the Elbe estuary.

mSystems·2026

Same journal

STED: flexible cross-modal topic modeling infers cell-type-specific regulatory landscapes from bulk epigenomics.

Briefings in bioinformatics·2026

Same journal

A knowledge-guided deep learning framework for quantitative nucleic acid testing.

Briefings in bioinformatics·2026

Same journal

Optimal transport for label transfer in single-cell multi-omics integration.

Briefings in bioinformatics·2026

Same journal

Continuous multi-omics pathway enrichment analysis resolves hidden functional heterogeneity.

Briefings in bioinformatics·2026

Same journal

Evaluating completeness, coherence, and consistency of genome-scale function annotations.

Briefings in bioinformatics·2026

Same journal

Transformers for single-cell RNA sequencing: a survey.

Briefings in bioinformatics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 16, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Bioinformatics for precision oncology.

Jochen Singer¹, Anja Irmisch², Hans-Joachim Ruscheweyh¹

¹Department of Biosystems Science and Engineering of ETH Zurich in Basel, Switzerland.

Briefings in Bioinformatics

|December 23, 2017

Summary

This summary is machine-generated.

Bioinformatics methods are crucial for analyzing complex tumor data in clinical oncology. These methods support molecular tumor boards in delivering precision oncology and personalized cancer treatments.

Keywords:

cancer clinical decision support data analysis pipeline molecular tumor board mutation calling

More Related Videos

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

Related Experiment Videos

Last Updated: Feb 16, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

Area of Science:

Oncology
Bioinformatics
Genomics

Background:

Molecular profiling of tumor biopsies is vital for cancer research and patient management.
Multi-omics approaches offer potential for enhanced diagnostics, prognostics, and personalized cancer treatments.
Precision oncology requires robust bioinformatics for managing and analyzing large, complex datasets.

Purpose of the Study:

To discuss the specific bioinformatics requirements for clinical oncology.
To outline the bioinformatics support needed for molecular tumor boards.
To review current and emerging clinical decision support software for precision oncology.

Main Methods:

Describing the workflow of a molecular tumor board.
Detailing bioinformatics support from raw data analysis to clinical report generation.
Reviewing efforts to integrate multi-omics data and clinical decision support tools.

Main Results:

Workflows for molecular tumor boards are implemented in clinical trials and cancer centers.
There is ongoing development to include high-dimensional multi-omics patient profiles.
Clinical decision support software is advancing to translate molecular findings into treatment recommendations.

Conclusions:

Effective bioinformatics methods are essential for the success of precision oncology.
Streamlined, reproducible bioinformatics workflows are critical for clinical decision-making.
Continued development of multi-omics integration and decision support tools will advance personalized cancer care.